US Patent Issued to GLAXOSMITHKLINE BIOLOGICALS on Jan. 27 for "Dosage and administration of a bacterial saccharide glycoconjugate vaccine" (Italian Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,418, issued on Jan. 27, was assigned to GLAXOSMITHKLINE BIOLOGICALS SA (Rixensart, Belgium).

"Dosage and administration of a bacterial saccharide glycoconjugate vaccine" was invented by Roberto Adamo (Siena, Italy), Giuseppe Del Giudice (Siena, Italy) and Sanjay Phogat (Siena, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a glycoconjugate for administration to a subject in a method comprising the steps of: (i) administering a first dose of glycoconjugate; (ii) subsequently administering a second dose of glycoconjugate; wherein the amount of glycoconjugate in the first dose or first and second doses are atypicall...